CN113200901A - Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof - Google Patents

Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof Download PDF

Info

Publication number
CN113200901A
CN113200901A CN202110430136.6A CN202110430136A CN113200901A CN 113200901 A CN113200901 A CN 113200901A CN 202110430136 A CN202110430136 A CN 202110430136A CN 113200901 A CN113200901 A CN 113200901A
Authority
CN
China
Prior art keywords
aryl
phenyl
reaction
aziridin
methanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110430136.6A
Other languages
Chinese (zh)
Inventor
殷燕
张青林
张华�
郭会峰
杨弘
翟九龙
王志海
李甜甜
谢悦悦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Technology
Original Assignee
Shanghai Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Technology filed Critical Shanghai Institute of Technology
Priority to CN202110430136.6A priority Critical patent/CN113200901A/en
Publication of CN113200901A publication Critical patent/CN113200901A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C07D203/24Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/02Preparation by ring-closure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/16Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
    • C07D203/18Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses an aziridine-2-yl- (aryl) ketone derivative and a preparation method thereof, wherein the preparation method comprises the steps of carrying out multi-step series reaction on 3-bit aryl substituted propiolic alcohol, N protected amine and N-halogenated succinimide to realize one-pot synthesis of the aziridine-2-yl- (aryl) ketone derivative. The yield of aziridine-2-yl- (aryl) ketone is 70-90%, and the method has the advantages of simple operation, mild conditions, high yield and the like, and provides a brand new synthetic method for the aziridine-2-yl- (aryl) ketone derivative.

Description

Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to an aziridine-2-yl- (aryl) ketone derivative and a preparation method thereof.
Background
Aziridin-2-yl- (aryl) methanones are important Organic intermediates which can be converted into nitrogenous compounds such as tetrahydropyrrole (Organic Letters,22(6), 2470. about. 2475, 2020; Angewandte. about. International Edition 55(28), 8081. about. 8085, 2016; Chemistry Letters 33(11), 1472. about. 1473, 2004; Bull. chem. Soc. Jpn. 78, 1309. about. 1333, 2005).
ZHenhua Liu et al reported a two-step reaction for the synthesis of aziridine from 2-azidoallyl alcohol (Scheme 1, Bull. chem. Soc. Jpn.,78, 1309-1333, 2005), the azide compound in this synthesis method is extremely unstable and not easy to operate in experiments, which limits its application range.
Figure BDA0003031145730000011
Takuya Hashimoto starts from β -chloropropiophenone and synthesizes aziridin-2-yl- (phenyl) methanone (Angew. chem. int. Ed.2016,55, 8081-8085, Scheme 2) by a two-step conversion, which has a two-step reaction and requires the relatively expensive 4-methyl-N- (tosyloxy) benzenesulfonamide.
Figure BDA0003031145730000012
From the above, the reported methods for preparing aziridin-2-yl- (aryl) methanone have the disadvantages of difficult availability of reaction raw materials and high preparation cost, or the instability and difficult operation of synthesized compounds.
Disclosure of Invention
The invention aims to solve the problems and provide an aziridine-2-yl- (aryl) ketone derivative which is simple to operate and high in reaction efficiency and a preparation method thereof.
The purpose of the invention is realized by the following technical scheme:
an aziridin-2 yl- (aryl) methanone derivative, the aziridin-2 yl- (aryl) methanone derivative having a structure according to the formula:
Figure BDA0003031145730000021
wherein: ar is phenyl, substituted phenyl, pyridyl, naphthyl or thienyl;
r is sulfonyl or acyl.
Preferably, Ar is phenyl, 3-fluoro-phenyl, 2-fluoro-phenyl 4-fluoro-phenyl, 4-chloro-phenyl, 4-bromo-phenyl, 4-methyl-phenyl, 4-phenyl, 4-methoxy-phenyl, 3-methoxy-phenyl, 2-naphthyl or 3-thienyl.
Preferably, R is benzenesulfonyl, 4-nitro-benzenesulfonyl, 4-methoxy-benzenesulfonyl, 4-fluoro-benzenesulfonyl, 4-chloro-benzenesulfonyl, 4-methyl-benzenesulfonyl, methanesulfonyl.
A process for the preparation of an aziridin-2-yl- (aryl) methanone derivative comprising the steps of:
(1) heating and refluxing 3 aryl-substituted propargyl alcohol, an acid catalyst and N-protected amine in a solvent, and obtaining a reaction solution containing a compound 1 after aryl-substituted propargyl alcohol completely disappears;
(2) then adding N-halogenated succinimide into the reaction liquid to obtain reaction liquid containing the compound 2;
(3) then cooling the reaction liquid to room temperature, and adding a proper amount of alkali into the reaction liquid to obtain reaction liquid containing the acyl aziridine derivative 3;
(4) extracting the reaction liquid with ethyl acetate, washing with saturated saline solution, evaporating, concentrating, and performing column separation to obtain aziridine-2-yl- (aryl) ketone derivative with purity of more than 98%;
the aryl-substituted propargyl alcohol has the structure shown below:
Figure BDA0003031145730000022
the N-protected amine has the structure shown below: RNH2
The structural formula of the halogenated succinimide is as follows:
Figure BDA0003031145730000031
the compound 1 has the following structure:
Figure BDA0003031145730000032
the compound 2 has the following structure:
Figure BDA0003031145730000033
R1i.e. R.
The preparation method has the following chemical reaction formula:
Figure BDA0003031145730000034
preferably, in the step (1), the heating reflux reaction temperature in the step (1) is 105-110 ℃, the time is 1-8 h, stirring is carried out in the process, and the stirring speed is 330-340 rpm;
the acid catalyst is Lewis acid and is selected from any one of ferric trifluoromethanesulfonate, bismuth trifluoromethanesulfonate, copper trifluoromethanesulfonate, silver trifluoromethanesulfonate and scandium trifluoromethanesulfonate; the progress of the reaction was monitored by TLC and when the aryl substituted propargyl alcohol starting material disappeared, the next step was carried out.
Preferably, in the step (1), the solvent is any one of dioxane, dichloroethane, trifluorotoluene, toluene, benzene, tetrahydrofuran or methanol;
and (3) the reaction temperature in the step (2) is 105-110 ℃, the time is 2-9 hours, stirring is carried out in the process, the stirring speed is 330-350 rpm, the reaction process is monitored by TLC, and the next step is carried out after the compound 1 in the reaction liquid disappears.
Preferably, in the step (2), the N-halogenated succinimide is NBS, NCS or NIS.
Preferably, in the step (3), the base is an organic base or an inorganic base, and is selected from any one of triethylamine, sodium hydroxide, potassium carbonate, sodium carbonate, calcium carbonate or magnesium carbonate;
and (3) the reaction temperature in the step (3) is room temperature, the time is 4-24 h, the reaction process is monitored by TLC, and the next step is carried out after the compound 2 in the reaction liquid disappears.
Preferably, the 3 aryl substituted propargyl alcohol, the N-protected amine, the N-halosuccinimide, the acid catalyst, and the base are present in a molar ratio of 1: (1.00-3.00): (1.00-2.00): (0.05-1.00): (0.50 to 2.00);
the ratio of the mole number of the 3 aryl-substituted propiolic alcohol to the volume number of the solvent is 1: 5 to 10 mol/L.
Compared with the prior art, the invention has the beneficial effects that:
the target product acyl aziridine is obtained through tandem Meyer-Schuster rearrangement reaction/intermolecular addition/alpha-halogenation reaction/cyclization reaction. The method has the advantages of easily available raw materials, simple operation, mild reaction conditions, high yield and the like. Comparing the reaction route in the literature with the reaction route, the raw materials used in the reaction are simpler and easier to obtain, and the experimental operation is more convenient and easier. The invention provides a brand-new one-pot synthesis method for synthesizing acyl aziridine.
Drawings
FIG. 1 is a photograph of the compound prepared in example 11H NMR spectrum;
FIG. 2 is a photograph of the compound prepared in example 113C NMR spectrum.
Detailed Description
The invention is described in detail below with reference to the figures and specific embodiments.
The raw materials used in the examples are commercially available products, and therefore, no other contents need to be provided.
The catalyst, dioxane, dichloroethane, benzotrifluoride, toluene, benzene, tetrahydrofuran, ethyl acetate, petroleum ether, anhydrous sodium sulfate and the like used in the embodiments of the invention are all Chinese medicine reagents.
The information of the equipment and the manufacturers used in the embodiments of the present invention is as follows:
the stirrer is as follows: a Shanghai plum Yimpu MYPII-2 constant-temperature magnetic stirrer;
the circulating water pump is as follows: shanghai Yukang circulation multipurpose vacuum pump SHB-IIIA;
the rotary evaporator comprises: shanghai yukang rotary evaporator W.S 206B;
the oil pump is as follows: shanghai Yukang 2XZ-2 type rotary-vane vacuum pump;
the preparative HPLC was: shimadzu LC-20A.
The preparation method of the aryl-substituted propargyl alcohol comprises the following steps:
a round bottom flask of appropriate size was taken and charged with aryl iodide (99.8% pure, 25g per flask), PdCl2(PPh3)2CuI; then, vacuumizing the reaction bottle and protecting the reaction bottle with nitrogen, then placing the reaction bottle in an ice-water bath, slowly dropwise adding excessive propargyl alcohol (the purity is 99.9 percent and the specification is 500g per bottle) into the reaction bottle at the speed of about 5 seconds per drop, and the required dropwise adding time is about five minutes; after the dripping is finished, the reaction bottle is placed at room temperature, and is placed in an oil bath pot after the temperature of the reaction bottle is recovered to the room temperature, and the reaction is carried out at 55-60 ℃.
Monitoring the reaction by TLC, and stopping the reaction after the aryl iodide is completely reacted; quenching the reaction by using a saturated sodium bicarbonate solution, extracting by using ethyl acetate, washing by using saturated saline solution, evaporating, concentrating and carrying out column separation to obtain the aryl-substituted propargyl alcohol compound with the purity of more than 98%.
In the examples, the general preparation method of acyl aziridine specifically includes the following steps: adding aryl substituted propiolic alcohol (0.10mmol), a solvent (0.50-1.00 mL), an acid catalyst (0.005-0.1 mmol), N-protected amine (0.10-0.30 mmol) and N-halogenated succinimide (0.1-0.2 mmol) into a 10mL sealed tube in sequence, carrying out reflux reaction, then cooling to room temperature, adding a base (0.05-0.20 mmol) for reaction, monitoring the reaction by TLC, and keeping the reaction for 5-33 h.
And finally, adding water into the reaction solution to quench the reaction, adding ethyl acetate to extract an organic phase, washing the obtained organic phase with saturated sodium chloride, drying the organic phase with anhydrous sodium sulfate, concentrating the dried organic phase on a rotary evaporator, and purifying the obtained concentrated solution by column chromatography to obtain the aziridine-2-yl- (aryl) ketone.
Example 1
Figure BDA0003031145730000051
Phenyl (1-tosylazido-2-yl) methanones
Aryl-substituted propargyl alcohol, an amine compound, N-halogenated succinimide, an acid catalyst, a solvent, alkali species and the use amounts thereof are respectively as follows: phenyl propynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-bromosuccinimide (0.15mmol), bismuth trifluoromethanesulfonate (0.005mmol),1, 4-dioxane (0.50mL), and potassium carbonate (0.20 mmol).
Light yellow liquid;1H NMR(500MHz,Chloroform-d)δ8.05(m,2H),7.87(d,J=10.5Hz,2H),7.62(t,J=9.0Hz,1H),7.49(t,J=10.0Hz,2H),7.34(d,J=10.0Hz,2H),4.17(dd,J=8.5,5.5Hz,1H),2.87(d,J=8.5Hz,1H),2.74(d,J=5.5Hz,1H),2.44(s,3H);13C NMR(125MHz,Chloroform-d)δ191.34,145.25,135.58,134.25,134.21,129.89,128.81,128.19,37.81,32.79,21.69.IR(KBr,cm-1):3473,3287,3069,2798,1664,1489,1445,1400,1320,1231,1163,1095,1020,954,895,808,728,682,565.yield:82%.HRMS calculated for C16H16NO3S([M+H]+):302.0851;found:302.0850.
Example 2
Figure BDA0003031145730000052
(2-fluorophenyl) (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 2-fluoropropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:81%.HRMS calculated for C16H15FNO3S([M+H]+):320.0757;found:320.0758.
Example 3
Figure BDA0003031145730000061
(3-fluorophenyl) (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 3-fluoropropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), ferric triflate (0.02mmol), dichloroethane (1.0mL), and potassium carbonate (0.20 mmol).
yield:80%.HRMS calculated for C16H15FNO3S([M+H]+):320.0757;found:320.0758.
Example 4
Figure BDA0003031145730000062
(4-fluorophenyl) (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 4-fluoropropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), bismuth trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium hydroxide (0.10 mmol).
yield:81%.HRMS calculated for C16H15FNO3S([M+H]+):320.0757;found:320.0758.
Example 5
Figure BDA0003031145730000071
(4-chlorophenyl) (1-toluenesulfonylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 4-Chlorophenylpropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and triethylamine (0.20 mmol).
yield:85%.HRMS calculated for C16H15ClNO3S([M+H]+):336.0461;found:336.0460.
Example 6
Figure BDA0003031145730000072
(4-bromophenyl) (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 4-bromophenylpropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol), methanol (0.50mL), and sodium carbonate (0.20 mmol).
yield:89%.HRMS calculated for C16H15BrNO3S([M+H]+):379.9956;found:379.9955.
Example 7
Figure BDA0003031145730000073
P-tolyl (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 4-Methylbenzpropiolic alcohol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:83%.HRMS calculated for C17H18NO3S([M+H]+):316.1007;found:316.1007.
Example 8
Figure BDA0003031145730000081
[1, 1' -Biphenyl ] -4-yl (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 4-Benzenepropanol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-bromosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.1 mmol).
yield:89%.HRMS calculated for C22H20NO3S([M+H]+):378.1164;found:378.1165.
Example 9
Figure BDA0003031145730000082
(2-methoxyphenyl) (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 2-methoxypropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:86%.HRMS calculated for C17H18NO4S([M+H]+):332.0957;found:332.0956.
Example 10
Figure BDA0003031145730000091
(3-methoxyphenyl) (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 3-methoxypropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:87%.HRMS calculated for C17H18NO4S([M+H]+):320.0757;found:320.0758.
Example 11
Figure BDA0003031145730000092
(4-methoxyphenyl) (1-tosylazido-2-yl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 4-methoxypropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:89%.HRMS calculated for C17H18NO4S([M+H]+):332.0957;found:332.0958.
Example 12
Figure BDA0003031145730000093
Naphthalen-2-yl (1-tosylazido-2-yl) methanones
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 2-Naphthylpropynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-bromosuccinimide (0.1mmol), bismuth trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:87%.HRMS calculated for C20H17NO3S([M+H]+):352.1007;found:352.1007.
Example 13
Figure BDA0003031145730000101
Thien-2-yl (1-tosylazido-2-yl) methanones
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: 2-thiophenylbenzynol (0.10mmol), p-methylbenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:81%.HRMS calculated for C14H14NO3S2([M+H]+):308.0415;found:308.0415.
Example 14
Figure BDA0003031145730000102
Phenyl (1- (phenylsulfonyl) azido-2-yl) methanones
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: phenylpropanol (0.10mmol), benzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:88%.HRMS calculated for C15H14NO3S([M+H]+):288.0694;found:288.0695.
Example 15
Figure BDA0003031145730000111
(1- ((4-nitrophenyl) sulfonyl) azido-2-yl) (phenyl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: phenylpropanol (0.10mmol), p-nitrobenzenesulfonamide (0.12mmol), N-chlorosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium carbonate (0.20 mmol).
yield:72%.HRMS calculated for C15H13N2O5S([M+H]+):333.0545;found:333.0546.
Example 16
Figure BDA0003031145730000112
(1- ((4-methoxyphenyl) sulfonyl) azido-2-yl) (phenyl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: phenylpropanol (0.10mmol), p-methoxybenzenesulfonamide (0.12mmol), N-iodosuccinimide (0.15mmol), copper trifluoromethanesulfonate (0.02mmol),1, 4-dioxane (0.50mL), and sodium hydroxide (0.20 mmol).
yield:90%.HRMS calculated for C16H16NO4S([M+H]+):318.0800;found:318.0801.
Example 17
Figure BDA0003031145730000113
((1- ((4-chlorophenyl) sulfonyl) azido-2-yl) (phenyl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: phenylpropanol (0.10mmol), p-chlorobenzenesulfonamide (0.15mmol), N-iodosuccinimide (0.2mmol), scandium trifluoromethanesulfonate (0.02mmol), toluene (0.50mL), and magnesium carbonate (0.20 mmol).
yield:76%.HRMS calculated for C15H13ClNO3S([M+H]+):322.0305;found:322.0306.
Example 18
Figure BDA0003031145730000121
(1- ((4-fluorophenyl) sulfonyl) azido-2-yl) (phenyl) methanone
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: phenyl propiolic alcohol (0.10mmol), p-fluorobenzenesulfonamide (0.3mmol), N-chlorosuccinimide (0.1mmol), silver triflate (0.06mmol), trifluorotoluene (0.50mL), and calcium carbonate (0.20 mmol).
yield:79%.HRMS calculated for C15H13FNO3S([M+H]+):306.0600;found:306.0601.
Example 19
Figure BDA0003031145730000122
Aziridine-1, 2-diylbis (benzophenone)
The aryl-substituted propargyl alcohol, the amine compound, the N-halogenated succinimide, the catalyst acid, the solvent, the catalyst base and the dosage thereof are respectively as follows: phenylpropanol (0.10mmol), benzamide (0.12mmol), N-bromosuccinimide (0.15mmol), bismuth trifluoromethanesulfonate (0.1mmol),1, 2-dichloroethane (1.0mL), and potassium hydroxide (0.30 mmol).
yield:70%.HRMS calculated for C16H14NO2([M+H]+):252.1025;found:252.1026.
The embodiments described above are described to facilitate an understanding and use of the invention by those skilled in the art. It will be readily apparent to those skilled in the art that various modifications to these embodiments may be made, and the generic principles described herein may be applied to other embodiments without the use of the inventive faculty. Therefore, the present invention is not limited to the above embodiments, and those skilled in the art should make improvements and modifications within the scope of the present invention based on the disclosure of the present invention.

Claims (10)

1. An aziridin-2 yl- (aryl) methanone derivative, characterized in that the aziridin-2 yl- (aryl) methanone derivative has the structure shown in the following formula:
Figure FDA0003031145720000011
wherein: ar is phenyl, substituted phenyl, pyridyl, naphthyl or thienyl;
r is sulfonyl or acyl.
2. An aziridin-2 yl- (aryl) methanone derivative according to claim 1, characterised in that Ar is phenyl, 3-fluoro-phenyl, 2-fluoro-phenyl-4-fluoro-phenyl, 4-chloro-phenyl, 4-bromo-phenyl, 4-methyl-phenyl, 4-phenyl, 4-methoxy-phenyl, 3-methoxy-phenyl, 2-naphthyl or 3-thienyl.
3. The aziridin-2 yl- (aryl) methanone derivative of claim 1, wherein R is benzenesulfonyl, 4-nitro-benzenesulfonyl, 4-methoxy-benzenesulfonyl, 4-fluoro-benzenesulfonyl, 4-chloro-benzenesulfonyl, 4-methyl-benzenesulfonyl, methanesulfonyl.
4. A process for the preparation of an aziridin-2 yl- (aryl) methanone derivative according to any of claims 1 to 3, comprising the steps of:
(1) heating and refluxing 3 aryl-substituted propargyl alcohol, an acid catalyst and N-protected amine in a solvent, and obtaining a reaction solution containing a compound 1 after aryl-substituted propargyl alcohol completely disappears;
(2) then adding N-halogenated succinimide into the reaction liquid to obtain reaction liquid containing the compound 2;
(3) then cooling the reaction liquid to room temperature, and adding a proper amount of alkali into the reaction liquid to obtain reaction liquid containing the acyl aziridine derivative 3;
(4) extracting the reaction liquid with ethyl acetate, washing with saturated saline solution, evaporating, concentrating, and performing column separation to obtain aziridine-2-yl- (aryl) ketone derivative with purity of more than 98%;
the aryl-substituted propargyl alcohol has the structure shown below:
Figure FDA0003031145720000012
the N-protected amine has the structure shown below: RNH2
The compound 1 has the following structure:
Figure FDA0003031145720000013
the compound 2 has the following structure:
Figure FDA0003031145720000014
5. the method of claim 4, wherein the aziridin-2-yl- (aryl) methanone derivative is prepared according to the following reaction scheme:
Figure FDA0003031145720000021
6. the method for preparing aziridin-2 yl- (aryl) methanone according to claim 4, wherein in the step (1), the heating reflux reaction temperature in the step (1) is 105-110 ℃, the time is 1-8 h, and the process is performed with stirring at 330-340 rpm;
the acid catalyst is Lewis acid and is selected from any one of ferric trifluoromethanesulfonate, bismuth trifluoromethanesulfonate, copper trifluoromethanesulfonate, silver trifluoromethanesulfonate and scandium trifluoromethanesulfonate; the progress of the reaction was monitored by TLC and when the aryl substituted propargyl alcohol starting material disappeared, the next step was carried out.
7. The method for preparing an aziridin-2 yl- (aryl) methanone derivative according to claim 4, wherein in the step (1), the solvent is any one of dioxane, dichloroethane, trifluorotoluene, toluene, benzene, tetrahydrofuran, or methanol;
and (3) the reaction temperature in the step (2) is 105-110 ℃, the time is 2-9 hours, stirring is carried out in the process, the stirring speed is 330-350 rpm, the reaction process is monitored by TLC, and the next step is carried out after the compound 1 in the reaction liquid disappears.
8. The method for preparing an aziridin-2 yl- (aryl) methanone derivative according to claim 4, wherein in the step (2), the N-halosuccinimide is NBS, NCS, NIS.
9. The method for preparing an aziridin-2 yl- (aryl) methanone derivative according to claim 4, wherein in the step (3), the base is an organic or inorganic base selected from any one of triethylamine, sodium hydroxide, potassium carbonate, sodium carbonate, calcium carbonate or magnesium carbonate;
and (3) the reaction temperature in the step (3) is room temperature, the time is 4-24 h, the reaction process is monitored by TLC, and the next step is carried out after the compound 2 in the reaction liquid disappears.
10. The method of claim 4, wherein the molar ratio of 3 aryl substituted propiolic alcohol, N protected amine, N-halosuccinimide, acid catalyst and base is 1: (1.00-3.00): (1.00-2.00): (0.05-1.00): (0.50 to 2.00);
the ratio of the mole number of the 3 aryl-substituted propiolic alcohol to the volume number of the solvent is 1: 5 to 10 mol/L.
CN202110430136.6A 2021-04-21 2021-04-21 Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof Pending CN113200901A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110430136.6A CN113200901A (en) 2021-04-21 2021-04-21 Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110430136.6A CN113200901A (en) 2021-04-21 2021-04-21 Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof

Publications (1)

Publication Number Publication Date
CN113200901A true CN113200901A (en) 2021-08-03

Family

ID=77027529

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110430136.6A Pending CN113200901A (en) 2021-04-21 2021-04-21 Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113200901A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107698469A (en) * 2017-10-13 2018-02-16 上海应用技术大学 A kind of preparation method of α halos β amino ketones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107698469A (en) * 2017-10-13 2018-02-16 上海应用技术大学 A kind of preparation method of α halos β amino ketones

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WEI JUNFA ET AL.: "A Rapid and Simple Method for Quantitative Aziridination frOm Am inobrominated Derivatives of Olefins under Solvent-free and Mild Conditions", 《CHIN.J.CHEM.》 *

Similar Documents

Publication Publication Date Title
CN107698469B (en) Preparation method of alpha-halogenated-beta-aminoketone
Li et al. One-pot, highly efficient, asymmetric synthesis of ring-fused piperidine derivatives bearing N, O-or N, N-acetal moieties
Griffiths-Jones et al. Carbenium ion trapping using sulfonamides: an acid-catalysed synthesis of pyrrolidines by intramolecular hydroamination
CN111646990A (en) Preparation method of 3, 4-bridged ring indole compound and synthesis method of Rucaparib
Kerr et al. Enantioselective N-heterocyclic carbene catalyzed formal [3+ 2] cycloaddition using α-aroyloxyaldehydes and oxaziridines
US5196607A (en) Process for preparing ketone enantiomer
CN113200901A (en) Aziridine-2-yl- (aryl) ketone derivative and preparation method thereof
CN106977386B (en) 2-trifluoroethyl-1-indanone and derivatives and preparation method thereof
Boultwood et al. Studies on the synthesis of α-iodoaziridines and improved conditions for the synthesis of alkyl-α-iodoaziridines using ClMgCHI2
Olofson et al. An efficient synthesis of enol carbonates
CN116478022A (en) Preparation method of alkynylamide-mediated ketone compound
TOYOTA et al. α-Fluorination of Methyl Phenyl Sulfoxide and Rlated Compounds by Molecular Fluorine; A Novel Method for the Introduction of Fluorine into Sulfoxides Bearing α-H Atoms
CN110467514B (en) Preparation method of alpha-halogenated unsaturated aldehyde ketone
CN113264865A (en) 2-amino-4-benzoyl-4, 5-dihydro-1H-pyrrole-3-carbon nitrile and preparation method thereof
JP3937489B2 (en) Method for producing propargylamine compound
Kim et al. A mild procedure for the stereospecific transformation of trans cinnamic acid derivatives to cis β-bromostyrenes
CN113200915A (en) 3-aryl-4, 5-dihydro-1H-pyrazole-5 amine and preparation method thereof
CN110183456A (en) A kind of synthetic method of 2- arylindazoles succinimide spiro-compound
CN113214183A (en) 5- (aminomethyl) -4-arylthiophene-2-amine derivative and preparation method thereof
CN113896647B (en) Synthesis method of tertiary amide
EP1023283B1 (en) Synthesis of 3-carbomethoxy-4,5-dimethylthiophene
Hu et al. A Synthetic Method for Diselenides Under Phase-Transfer Conditions
CN113004321B (en) Method for desymmetrizing 3-substituted cyclobutanone, cyclobutene compound and application thereof
CN112321398B (en) Method for synthesizing alpha-fluorinated ketone by hydrazonating aliphatic chain monoketone
CN110256247B (en) Synthesis method of 2- ((9-hydrofluoren-9-yl) methyl) malonate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210803

RJ01 Rejection of invention patent application after publication